• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,508.54 899.56
( 1.21%)
Global Indices
Nasdaq
49,714.12 -67.45
(-0.14%)
Dow Jones
7,466.35 44.39
(0.60%)
Hang Seng
62,791.91 -480.20
(-0.76%)
Nikkei 225
10,300.99 35.67
(0.35%)
Forex
USD-INR
95.60 0.47
(0.49%)
EUR-INR
112.29 0.30
(0.26%)
GBP-INR
129.50 0.02
(0.02%)
JPY-INR
0.61 0.00
(0.19%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.394924
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
28.97
107204.87
EPS(TTM)
Face Value()
Div & Yield %
45.81
2
0.98
 

bmb music & magnetics ltd
Ashok Leyland’s total sales climb 9% YoY to 14,646 units in April’26
May 04,2026
Total medium & heavy commercial vehicle (M&HCV) sales jumped 4% YoY to 8,302 units in April 2026, while light commercial vehicle (LCV) sales climbed 16% YoY to 6,344 units in April 2026.

In the domestic market, total vehicle sales increased 14% YoY to 14,242 units in April 2026, compared with 12,509 units in April 2025. Domestic M&HCV sales rose 8% YoY to 7,977 units, while LCV sales climbed 23% YoY to 6,265 units.

Ashok Leyland is involved in the manufacture and sale of a broad range of commercial vehicles and also makes engines for industrial and marine applications, as well as forgings and castings.

The company’s consolidated net profit increased 6.8% YoY to Rs 813.49 crore in Q3 FY26 compared with Rs 761.92 crore in Q3 FY25. Net sales jumped 23.6% to Rs 14,761.95 crore in the quarter ended 31st December 2025.

The scrip rose 0.03% to Rs 162.15 on the BSE.